146 related articles for article (PubMed ID: 36963801)
1. Outcomes associated with treatment to all sites of disease in patients with stage IVB cancer of the cervix.
Peleg Hasson S; Felder S; Helpman L; Taylor A; Shalamov M; Abuakar S; Bauer S; Shapira-Frommer R; Greenhouse I; Korach J; Rabin T; Goldstein J; Saad A
Int J Gynecol Cancer; 2023 May; 33(5):683-691. PubMed ID: 36963801
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors in definitive radiotherapy of uterine cervical cancer.
Yalman D; Aras AB; Ozkök S; Duransoy A; Celik OK; Ozsaran Z; Haydaroğlu A
Eur J Gynaecol Oncol; 2003; 24(3-4):309-14. PubMed ID: 12807246
[TBL] [Abstract][Full Text] [Related]
3. Oncologic Outcomes of Stage IVB or Persistent or Recurrent Cervical Carcinoma Patients Treated With Chemotherapy at Siriraj Hospital: Thailand's Largest Tertiary Referral Center.
Ruengkhachorn I; Leelaphatanadit C; Therasakvichya S; Hunnangkul S
Int J Gynecol Cancer; 2016 Jul; 26(6):1154-61. PubMed ID: 27051060
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic characteristics and survival analysis in stage IVB cervical cancer with hematogenous metastasis.
Li H; Yang Y; Zhou H; Liu F; Li M; Chen L; Wu X; Cheng X
Transl Cancer Res; 2019 Aug; 8(4):1217-1223. PubMed ID: 35116863
[TBL] [Abstract][Full Text] [Related]
5. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy].
Ma R; Zhang H; Zou L; Qu Y
Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):125-30. PubMed ID: 25877610
[TBL] [Abstract][Full Text] [Related]
6. Stage IIB-IVB cervical adenocarcinoma: prognostic factors and survival.
Lea JS; Sheets EE; Wenham RM; Duska LR; Coleman RL; Miller DS; Schorge JO
Gynecol Oncol; 2002 Jan; 84(1):115-9. PubMed ID: 11748986
[TBL] [Abstract][Full Text] [Related]
7. Burden of lymphatic disease predicts efficacy of adjuvant radiation and chemotherapy in FIGO 2018 stage IIICp cervical cancer.
Bogani G; Vinti D; Murgia F; Chiappa V; Leone Roberti Maggiore U; Martinelli F; Ditto A; Raspagliesi F
Int J Gynecol Cancer; 2019 Nov; 29(9):1355-1360. PubMed ID: 31422352
[TBL] [Abstract][Full Text] [Related]
8. Open versus laparoscopic pelvic lymph node dissection in early stage cervical cancer: no difference in surgical or disease outcome.
van de Lande J; von Mensdorff-Pouilly S; Lettinga RG; Piek JM; Verheijen RH
Int J Gynecol Cancer; 2012 Jan; 22(1):107-14. PubMed ID: 21857347
[TBL] [Abstract][Full Text] [Related]
9. Stage IVb thymic carcinoma: patients with lymph node metastases have better prognoses than those with hematogenous metastases.
Yang Y; Fan XW; Wang HB; Xu Y; Li DD; Wu KL
BMC Cancer; 2017 Mar; 17(1):217. PubMed ID: 28347273
[TBL] [Abstract][Full Text] [Related]
10. Comparison of salvage therapies for isolated para-aortic lymph node recurrence in patients with uterine cervical cancer after definitive treatment.
Kubota H; Tsujino K; Sulaiman NS; Sekii S; Matsumoto Y; Ota Y; Soejima T; Yamaguchi S; Sasaki R
Radiat Oncol; 2019 Dec; 14(1):236. PubMed ID: 31878944
[TBL] [Abstract][Full Text] [Related]
11. [Outcomes and prognosis of radical surgery in patients with stageⅠb2 and Ⅱa2 cervical squamous cell carcinoma].
Zhou F; Chen F; Pan T; Zhu T; Zhang YL; Zhang P; Tang HR
Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):361-369. PubMed ID: 35658327
[No Abstract] [Full Text] [Related]
12. Surgery of primary sites for stage IVB cervical cancer patients receiving chemoradiotherapy: a population-based study.
Li H; Pang Y; Cheng X
J Gynecol Oncol; 2020 Jan; 31(1):e8. PubMed ID: 31788998
[TBL] [Abstract][Full Text] [Related]
13. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
[TBL] [Abstract][Full Text] [Related]
14. Review of Treatment and Prognosis of Stage IVB Cervical Carcinoma.
Usami T; Takahashi A; Matoda M; Okamoto S; Kondo E; Kanao H; Umayahara K; Takeshima N
Int J Gynecol Cancer; 2016 Sep; 26(7):1239-45. PubMed ID: 27643648
[TBL] [Abstract][Full Text] [Related]
15. Incorporation of whole pelvic radiation into treatment of stage IVB cervical cancer: A novel treatment strategy.
Perkins V; Moore K; Vesely S; Matsuo K; Mostofizadeh S; Sims TT; Lea J; Barnes D; Chen S; Carlson M; Roman L; Monk BJ; Holman LL
Gynecol Oncol; 2020 Jan; 156(1):100-106. PubMed ID: 31810653
[TBL] [Abstract][Full Text] [Related]
16. Consolidation chemotherapy in early-stage cervical cancer patients with lymph node metastasis after radical hysterectomy.
Zhong ML; Wang YN; Liang MR; Liu H; Zeng SY
Int J Gynecol Cancer; 2020 May; 30(5):602-606. PubMed ID: 32156715
[TBL] [Abstract][Full Text] [Related]
17. Matched-case comparison for the role of surgery in FIGO stage Ib1-IIa squamous cell carcinoma of cervix and suspicious para-aortic lymph node metastasis.
Kim HS; Park NH; Wu HG; Cho JY; Chung HH; Kim JW; Song YS; Kim SH; Kang SB
Ann Surg Oncol; 2009 Jan; 16(1):133-9. PubMed ID: 18979134
[TBL] [Abstract][Full Text] [Related]
18. Effect of addition of bevacizumab to chemoradiotherapy in newly diagnosed stage IVB cervical cancer: a single institution experience in Korea.
Youn SH; Kim YJ; Seo SS; Kang S; Lim MC; Chang HK; Park SY; Kim JY
Int J Gynecol Cancer; 2020 Jun; 30(6):764-771. PubMed ID: 32276937
[TBL] [Abstract][Full Text] [Related]
19. Patterns of Recurrence in Node-Positive Cervical Cancer Patients Treated With Contemporary Chemoradiation and Dose Escalation: A Multi-Institutional Study.
Sethi R; Mayadev J; Sethi S; Rash D; Chen LM; Brooks R; Ueda S; Hsu IC
Pract Radiat Oncol; 2019 Mar; 9(2):e180-e186. PubMed ID: 30342181
[TBL] [Abstract][Full Text] [Related]
20. The influence of hematogenous and serosal metastases on advanced (FIGO IIA-IVB) squamous cell carcinoma of the cervix.
DeEulis TG; Markoe AM; Sedlacek TV; Brady LW
Am J Clin Oncol; 1987 Feb; 10(1):10-20. PubMed ID: 3825988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
